A tech powerhouse I've been tracking closely has gained some 290% over the past five years. Plus, a beat-and-raise quarter sent shares up more than 6% on November 6 when the Nasdaq Composite was still in a correction. That kind of strength in...
Quick: Choose between buying 1) a biotech exchange-traded fund that trades about 2.3 million shares a day or 2) a tech ETF that trades less than 7,300 shares per day.
If you chose 1, in this case you’d be wrong – but I understand your decision there.
After all, to make money in tech stocks you must consider volume, along with price action, fundamentals and other factors. That’s because some microcap stocks are so thinly traded that you might not be able to get out quickly should you need to.
Personally, I like to see at least 50,000 shares trading hands daily on small caps – and much more for larger firms. And 7,300 shares a day is far below those sorts of numbers.
However, when it comes to ETSs, volume is much less important than three other metrics you should consider when looking at these funds.
These three elements can mean the difference between riches and financial ruin.
You’ve no doubt heard about earnings reports coming out from top Canadian cannabis companies.
And the news has been a mixed bag.
Aurora Cannabis Inc. (NYSE:ACB), for instance, got the week started by reporting revenue of $22 million for its first fiscal quarter of 2019. That’s up 55% from the prior quarter – and 260% from the year-ago period.
As we’ve expected, growingly popular cannabis extracts have been a big seller for Aurora, making up some 30% of its total cannabis-based sales thus far. Further, the firm claims it owns almost a third of online recreational sales in Canada’s largest province, Ontario.
“The commencement of adult consumer use sales in Canada has been very successful for Aurora, with strong performance across all product categories and brands,” CEO Terry Booth said.
Remember Tilray Inc. (Nasdaq:TLRY)? That’s the cannabis superstar whose shares skyrocketed after joining the Nasdaq in June. Revenue for the firm, which it reported Wednesday, climbed 86% to $10 million from a year ago, with medical cannabis demand in and outside Canada accounting for most of the growth. However, the firm also reported a net loss of $18.7 million for the third quarter – and share prices dropped more than 5% on the news.
Here’s the thing. This is no time to panic about the fate of the cannabis industry, particularly the best firms in this space.
In fact, a whole new slew of profit catalysts are lining up right now that are going to send cannabis stocks soaring.
While the price of major cryptocurrencies like Bitcoin(BTC) and Ethereum (ETH) remain choppy this year, businesses and investors across the globe have been busy exploring ways they can best use blockchain technology.
They’re trying to harness the tech to improve or streamline operations in a wide range of industries – from financial services, media, and telecom to transportation, healthcare, and consumer or industrial products.
The idea here is that the blockchain can provide a digital store of value, eliminate the middleman currently required in many digital transactions, quicken settlement between parties, and authenticate transactions in an immutable way.
And that’s just the beginning.
So this is going to be a big industry, with a big market.
WinterGreen Research estimates the worldwide market for blockchain products was $706 million last year and could reach more than $60 billion by 2024. That’s 8,400% growth in less than a decade – and that’ll lead to the kinds of gains no one can ignore.
But today, I want to focus on a smaller sector within the blockchain world. It’s got explosive profit potential all on its own.
Then I’m going to show you three ways to make money on this blockchain revolution.
You know how legal marijuana stocks can pile up big gains.
In fact, no fewer than 64 cannabis stocks have already shot past 1,000% gains in the last few years.
And those big gains – which often come in just a few weeks – are many times supercharged by big catalysts.
Like the voters in four states deciding tomorrow on whether to legalize cannabis. (Click here to watch my full rundown on all the legal cannabis profit opportunities my Election Day research has revealed.)
Folks in Michigan and North Dakota are deciding on adult-use recreational cannabis. And voters in Utah and Missouri are taking up medical marijuana legislation.
Meanwhile, dozens of cities and counties in California, Ohio, and Wisconsin have put the legalization question to their voters. (Ohioans are also deciding on whether to decriminalize small amounts of cannabis.)